FDA approves ZAVZPRET label update; Pfizer registers RSVpreF and prostate cancer studiesAug 21Weekly roundup, 7 itemsBioNTech SEPenbraya
Olema completes OPERA-01 enrollment, pushes top-line data to Q1 2027Aug 10Quarterly updateOlema Pharmaceuticals, Inc.
Janux reports Q2 2026 results, keeps prostate cancer and autoimmune programs on trackAug 6Quarterly updateJanux TherapeuticsJANX007
Vir reports Week 96 SOLSTICE data, ECLIPSE program fully enrolled, VIR-5500 expansion underwayAug 5Quarterly updateVir Biotechnology, Inc.VIR-5500
ORIC Pharmaceuticals starts Phase 3 Himalayas-1 trial, adds Bayer supply dealAug 3Quarterly updateORIC Pharmaceuticals
ORIC Pharmaceuticals registers Phase 3 Himalayas-1 trial for rinzimetostat in mCRPCJul 23Trial updateBayerdarolutamide
Sign inSign in